Melanoma Research

Article	Citations
Genetic concordance in melanoma: insights from primary tumors and their matched distant metastases	22
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel	17
Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread	17
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting	17
Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases	17
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?	15
Clinical features, molecular characteristics and surgical management of primary penile mucosal melanoma based on the European Association of Urology Penile Cancer Guidelines	13
Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy	13
Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan	13
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors	13
Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model	12
Brain metastases during follow-up of patients with resected cutaneous melanoma	11
Study of clinical characteristics and risk factors for amelanotic/hypomelanotic melanoma in an Australian cohort	10
Melanotransferrin is efficiently sorted on the surface of exosomes secreted by melanoma cells	10
Assessment of lipid and pigment content in suspicious melanocytic lesions to improve melanoma detection	10
The potential of using artificial intelligence to improve skin cancer diagnoses in Hawai‘i’s multiethnic population	10
Relationships between survival and real-world recurrence-free survival or distant metastasis-free survival among patients with completely resected stage IIB or IIC melanoma	9
Pretreatment CD8+PD-1+ to CD4+PD-1+ ratio is associated with the prognosis of advanced melanoma patients treated with PD-1 inhibitors	9
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma	9
Do cortisol and psychological distress levels impact the effectiveness of immunotherapy in patients with metastasized melanoma? A pilot study	9
Association of baseline neutrophil-to-lymphocyte ratio and prognosis in melanoma patients treated with PD-1/PD-L1 blockade: a systematic review and meta-analysis	9
Diffuse large B-cell lymphoma mimicking metastatic melanoma: the importance of biopsies in the era of immune checkpoint inhibitors	9
Cytomegalovirus gastritis as a rare adverse event during combined ipilimumab and nivolumab in a patient with melanoma	9
Ultraviolet A radiation exposure and melanoma: a review	9
Electrical impedance spectroscopy significantly enhances correct biopsy choice for pigmented skin lesions beyond clinical evaluation and dermoscopy	8

Challenging pigmented lesions in melanoma patients during checkpoint-inhibitors therapy	8
Temporal correlation between the first melanoma and the first noncutaneous tumor in CKDN2A genotyped patients	8
Diagnostic and prognostic value of Beclin 1 expression in melanoma: a meta-analysis	8
LINC01063 functions as an oncogene in melanoma through regulation of miR-5194-mediated SOX12 expression	8
The role of osteopontin in the development and metastasis of melanoma	8
Clinical and dermoscopical presentation of nivolumab-induced pemphigoid in a metastatic melanoma patient	8
Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis: Erratum	8
Regular use of vitamin D supplement is associated with fewer melanoma cases compared to non-use: a cross-sectional study in 498 adult subjects at risk of skin cancers	8
Immunotherapy-induced granulomatous reaction in patients with melanoma	8
Uncomplicated pregnancy and delivery under ongoing nivolumab therapy for metastatic melanoma	7
Successful encorafenib desensitization in a patient with recurrent metastatic melanoma	7
Hemophagocytic lymphohistiocytosis induced by dabrafenib-trametinib in a patient with metastatic melanoma: a case report and pharmacovigilance analysis	7
Neurologic adverse events associated with BRAF and MEK inhibitor therapy in patients with malignant melanoma: a disproportionality analysis using the Food and Drug Administration Adverse Event Reporti	7
Immunotherapy for treatment of female genital tract melanoma: National Cancer Database analysis	7
Documenting the histologic response of metastatic melanoma to combination therapy with BRAF and MEK inhibitors	7
Exacerbation of Kaposi sarcoma following BRAF/MEK inhibitor therapy in a melanoma patient: a case report and mechanistic insight	7
GLI-1 polymorphisms of Hedgehog pathway as novel risk and prognostic biomarkers in melanoma patients	7
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series	7
Clostridium difficile infection and immune checkpoint inhibitor–induced colitis in melanoma: 18 cases and a review of the literature	7
Interfering with aggregated α-synuclein in advanced melanoma leads to a major upregulation of MHC class II proteins	6
Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma	6
Efficacy and safety of angiogenesis inhibitors in melanoma: a meta-analysis of seven randomized controlled trials	6
Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition	6
Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases	6
The effect of microRNA-9 overexpression on inhibition of melanoma cancer stem cells tumorigenicity	6
ETS1 promoted cell growth, metastasis and epithelial–mesenchymal transition process in melanoma by regulating miR-16-mediated SOX4 expression	6
Exceptional response to combination ipilimumab and nivolumab in metastatic uveal melanoma: Insights from genomic analysis	5
Intratumoural and systemic inflammation as predictors for treatment response in BRAF-mutated melanoma patients under targeted therapies	5
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma	5
Temozolomide monotherapy versus combination therapies in melanoma: a meta-analysis of efficacy and safety	5
Variance from published guidelines and changes in temporal trends in the management of cutaneous malignant melanoma: a 5-year update	5
Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment	5
Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors	5
Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patients	5
Proteomic profiles of melanoma cell-derived exosomes in plasma: discovery of potential biomarkers of melanoma progression	5
Knockdown of enhancer of rudimentary homolog expression attenuates proliferation, cell cycle and apoptosis of melanoma cells	5
Simultaneous melanomas in the setting of multiple primary melanomas	5
Combined PDE4+MEK inhibition shows antiproliferative effects in NRAS Q61 mutated melanoma preclinical models	4
Molecular profiling of primary uveal melanoma: results of a Polish cohort	4
Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients	4
Updates on the diagnosis, current and future therapeutic options in Merkel-cell carcinoma	4
Melanoma risk during immunomodulating treatment	4
Hidden in plain sight: the (other) danger of COVID-19	4
Successful use of rituximab for refractory hemophagocytic lymphohistiocytosis in a melanoma patient treated with targeted therapy	4
Melanoma in the head and neck region: the value of preoperative imaging in melanoma stage I–II	4
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era	4
Intracranial hemorrhage caused by dabrafenib and trametinib therapy for metastatic melanoma	4
Identification of heterogeneity and prognostic key genes associated with uveal melanoma using single-cell RNA-sequencing technology	4
Patterns of radiological response to tebentafusp in patients with metastatic uveal melanoma	4
Seborrheic keratosis-like melanoma: a diagnostic challenge	4

The human and animals’ malignant melanoma: comparative tumor models and the role of microbiome in dogs and humans	4
COVID-19 vaccination mimicking lymph-node progression in a patient with melanoma: a case report	4
DNA methylation of GITR, OX40, 4-1BB, CD27, and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanoma	4
The immunologic balance: three cases of rituximab-associated melanoma	4
A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors	3
Reflectance confocal microscopy versus dermoscopy for the diagnosis of cutaneous melanoma: a head-to-head comparative meta-analysis	3
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma	3
Efficacy of local ablative therapies in patients with solid tumors treated with immune checkpoint inhibitors and oligoprogression: a single-center analysis	3
PET-CT for staging pT4b melanomas prior to sentinel lymph node biopsy: a 5-year review	3
Uveal melanoma metastatic at initial diagnosis: a case series	3
Metastatic acral melanoma treatment outcomes: a systematic review and meta-analysis	3
Correlations between inflammatory cytokine levels and degree of pigmentation in acral melanomas	3
Relevance of detection of RAF fusion transcripts in pan-negative melanoma in routine practice	3
Induction of T helper 17 cell response by interleukin-7 in patients with primary cutaneous melanoma	3
Lower melanoma pulmonary metastatic burden in obese mice: role of FGF-21	3
Management of heterogeneous tumor response patterns to immunotherapy in patients with metastatic melanoma	3
Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma	3
Psychosocial wellbeing in people with melanoma in-situ: a systematic review	3
Leptomeningeal dissemination as a first sign of progression in metastatic melanoma: a diagnostic lesson	3
Neonatal cutaneous melanoma with cutaneous metastasis: a case report and review of literature	3
Isolated limb perfusion with melphalan as treatment for regionally advanced melanoma of the limbs: results of 60 patients treated in Finland during 2007–2018	3
Noncontrast-enhanced 3-Tesla MRI using surface coil as a complementary test for assessment of distribution and depth of locoregional cutaneous metastases of malignant melanoma	3
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies	3
Direct early growth response-1 knockdown decreases melanoma viability independent of mitogen-activated extracellular signal-related kinase inhibition	3
Impact of the development of immune related adverse events in metastatic melanoma treated with PD -1 inhibitors	3
A retrospective study of clinicopathological and prognostic characteristics in 177 Chinese patients with acral melanoma: heterogeneity based on tumor site	3
Ultra-high-frequency ultrasound monitoring of melanomas arising in congenital melanocytic nevi: a case series	3
Safety of combining dabrafenib plus trametinib in elderly BRAF V600 mutation-positive advanced melanoma patients: real-world data analysis of Spanish patients (ELDERLYMEL)	3
Survival in adult patients with BRAFV600 mutation-positive advanced melanoma: a noninterventional ambispective study of patients with cobimetinib combined with vemurafenib during the French early acce	3
First-time office visit for suspicious skin lesion evaluation as a predictor of high-risk melanoma	3
Assessing melanoma prognosis: the interplay between patient profiles, survival, and BRAF, NRAS, KIT, and TWT mutations in a retrospective multi-study analysis	3
Clinical significance of CCNE1 copy number gain in acral melanoma patients	3
Retrospective comparison of a weight-based dose every 2 weeks with a fixed dose every month: a real-life analysis of nivolumab in the treatment of advanced melanoma	3
The death rate for melanoma remained unchanged in the USA during the coronavirus disease 2019 pandemic	2
Survivals following discontinuation of PD-1 inhibitor treatment in advanced melanoma patients	2
Impact of gene expression profiling on diagnosis and survival after metastasis in patients with uveal melanoma	2
Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma	2
Eruptive melanocytic nevi in a patient with amelanotic melanoma: a paraneoplastic phenomenon?	2
ATF3 regulates CDC42 transcription and influences cytoskeleton remodeling, thus inhibiting the proliferation, migration and invasion of malignant skin melanoma cells	2
Talimogene laherparepvec monotherapy for head and neck melanoma patients	2
Retrospective analysis of adjuvant therapy using dabrafenib plus trametinib in Japanese patients with advanced melanoma: analysis of 36 cases	2
Diagnosis and management of concurrent metastatic melanoma and chronic myelomonocytic leukemia	2
Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis	2
Vitiligo-like hypopigmentation secondary to adjuvant checkpoint inhibitor therapy in patients with resectable stage III melanoma: a cohort from two tertiary hospitals	2
LS-007 inhibits melanoma growth via inducing apoptosis and cell cycle arrest and regulating macrophage polarization	2
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors	2
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma	2
Prognostic significance of tumor budding in melanoma	2
Safety of immune checkpoint inhibitors after proton beam therapy in head and neck mucosal melanoma: a case series	2
Polymorphisms in toll-like receptor 3 and 4 genes as prognostic and outcome biomarkers in melanoma patients	2
Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma	2
Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study	2
Clinical features of vulvar and vaginal malignant melanomas and the effects of immune checkpoint inhibitors in Japanese patients: a single-center, retrospective cohort study	2
Patient-reported outcomes in randomized controlled trials evaluating BRAF inhibitors in patients with cutaneous melanoma: a systematic scoping review of quality of reporting and trial results	2
Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020	2
A case of hyperprolactinaemia in a patient with metastatic melanoma	2
Expression of cathepsins B and D by cancer stem cells in head and neck metastatic malignant melanoma	2
Pembrolizumab-induced hypothyroidism manifesting as myopathy and psychosis	2
Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanoma	2
Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective	2
BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: a novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome	2
Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy	2
Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging	2
The importance of mitosis ≥2 in selecting patients with T1 cutaneous melanomas for sentinel lymph node biopsy	2
High-resolution RNA-sequencing reveals TRIM33::CSDE1 gene fusion in metastasizing vulvar melanoma	2
Open-label nonrandomized phase IB study to characterize the safety and recommended dose of tinostamustine in combination with nivolumab in patients with advanced melanoma (ENIgMA)	2
Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma	2
Female melanoma and estrogen receptors expression: an immunohistochemical pilot study	2
Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma	2
Influence of regression, its extent and tumor-infiltrating lymphocytes on sentinel node status, relapse, and survival in a 10-year retrospective study of melanoma patients	2
The effect of COVID-19 on early melanoma detection	2
Expect the unexpected: a saying to bear in mind	2
Treatment outcomes following partial shave biopsy of atypical and malignant melanocytic tumors in pediatric patients	1
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy	1
Macrophage inhibitory cytokine-1 produced by melanoma cells contributes to melanoma tumor growth and metastasis in vivo by enhancing tumor vascularization	1
Steroid-refractory severe immune-related mucositis following adjuvant anti-PD-1 therapy for resectable melanoma: a case report	1
Tocilizumab in the treatment of steroid refractory immune-related hepatotoxicity: a case series and review of the literature	1
A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio	1
Regorafenib in patients with pretreated advanced melanoma: a single-center case series	1
Total body skin examination visits by dermatology providers in the 2011–2016 National Ambulatory Medical Care Survey	1

Melanoma risk prediction based on a polygenic risk score and clinical risk factors	1
Use of laboratory hematology data in melanoma research: comments on “A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio” Melanoma Res	1
Targeting cyclin-dependent kinase 4/6 as a therapeutic approach for mucosal melanoma	1
Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients	1
Underreporting of acral lentiginous melanoma in studies informing American Joint Committee on Cancer Staging System Guidelines: a review of 150 cited studies	1
Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanoma	1
pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanoma	1
Response of metastatic melanoma with a rare BRAF V600K mutation to dabrafenib and trametinib	1
Novel strategy for applying hierarchical density-based spatial clustering of applications with noise towards spectroscopic analysis and detection of melanocytic lesions	1
Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia: a case series and	1
Pembrolizumab-induced acquired lipodystrophy: a case report and review of the literature	1
Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis	1
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma: Erratum	1
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma	1
Expression of the cancer stem cell marker OCT4 is associated with worse prognosis and survival in cutaneous melanoma	1
Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patients	1
The association between dermatologist density and melanoma prognosis using melanoma mortality-incidence ratio	1
Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s)	1
Description of supportive care and feasibility of physical exercise program to improve quality of life in advanced melanoma patients	1
Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study	1
Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene	1
Fertility preservation for patients with melanoma	1
CD103 and periplakin are potential biomarkers for response of metastatic melanoma to pembrolizumab	1
Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapy	1
Cardiovascular disease and malignant melanoma	1
Real-world relapse-free survival data on adjuvant anti-PD-1 therapy for patients with newly diagnosed and recurrent stage III melanoma	1
Pediatric melanoma incidence and survival: a fifteen-year nationwide retrospective cohort study in Korea	1
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort	1
Prognosis of polypoid melanoma: a comparative study with non-polypoid melanomas	1
Development and validation of prognostic nomogram in pediatric melanoma: a population-based study	1
The role of wide local excision of a primary lesion in cutaneous malignant melanoma: a retrospective analysis of its usefulness in local and general control of disease	1
C-reactive protein as a biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting	1
Effectiveness and safety of talimogene laherparepvec and granulocyte-macrophage colony-stimulating factor for metastatic melanoma: a systematic review and network meta-analysis of randomized controlle	1
Quality of life after melphalan percutaneous hepatic perfusion for patients with metastatic uveal melanoma	1
Hypoxic transcriptomes predict survival and tumor-infiltrating immune cell composition in cutaneous melanoma	1
Cost-effectiveness analysis of an orphan drug-tebentafusp in patients with metastatic uveal melanoma and a call for value-based pricing	1
Nivolumab-induced immune-mediated acute gastritis in a melanoma patient	1
Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-int	1
Preoperative assessment of cutaneous melanoma thickness by multispectral dermoscopy	1
Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case report	1
New technique for in-continuity axillary and supraclavicular lymphadenectomy for advanced metastatic melanoma using intraoperative image guidance: a case report	1
Vitamin D deficiency in melanoma patients is associated with worse overall survival: a retrospective cohort study	1
The role of artificial intelligence and convolutional neural networks in the management of melanoma: a clinical, pathological, and radiological perspective	1
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experience	1
Low-dose ipilimumab combined with anti-PD-1 immunotherapy in patients with metastatic melanoma following anti-PD-1 treatment failure	1
Melanoma cell plasticity poses diagnostic challenges: a case series	1
Resistance to anti-PD1 therapies in patients with advanced melanoma: systematic literature review and application of the Society for Immunotherapy of Cancer Immunotherapy Resistance Taskforce anti-PD1	1
Transcutaneous sentinel lymph node detection in skin melanoma with near-infrared fluorescence imaging using indocyanine green	1
Tumour regression predicts better response to interferon therapy in melanoma patients: a retrospective single centre study	1
The inhibitory role of microRNA-141-3p in human cutaneous melanoma growth and metastasis through the fibroblast growth factor 13-mediated mitogen-activated protein kinase axis	1